Revvity Inc's ability to collect accounts receivable sequentially worsen to 4.03, pointing to a challenging and on top of that deteriorating business climate for the Laboratory Analytical Instruments industry. Revvity Inc's Accounts Receivable average collection period in the Jul 05 2026 quarter, has increased to 91 days, from 87 days, in the Apr 05 2026 quarter.

If we take a look into Healthcare sector 442 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2953, from overall ranking in the first quarter 2026 at 3289.

What is Receivable Turnover Ratio?
What is Revvity Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RVTY Receivables Turnover Ratio	(Jul 05 2026) II. Quarter	(Apr 05 2026) I. Quarter	(Dec 28 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter
Y / Y Receivable Change	17.58 %	11.98 %	17.75 %	12.97 %	10.66 %
Y / Y Revenue Change	1.31 %	6.97 %	5.85 %	2.18 %	4.13 %
Receivable Turnover Ratio (TTM)	4.03	4.18	4.23	4.34	4.45
RVTY's Total Ranking	# 2953	# 3289	# 2984	# 2982	# 3006
Accounts Receivable average collection period days	91	87	86	84	82
Seq. Receivable Change	12.44 %	-7.16 %	9.47 %	2.89 %	7.08 %
Seq. Revenue Change	2.61 %	-7.89 %	10.46 %	-2.96 %	8.35 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 19
Healthcare Sector	# 443
Overall Market	# 2953

Receivable Turnover Ratio Statistics
High	Average	Low
6	4.99	4.03
(Jul 02 2023)		(Jul 05 2026)

RVTY Company Profile • Back to RVTY Efficiency Comparisons • Compare RVTY Receivables Turnover Ratio to its Competitors

Financial Statements
Revvity Inc's Accounts Receivable	$ 777 Millions	Visit RVTY's Balance sheet
Revvity Inc's Sales TTM	$ 2,912 Millions	Visit RVTY's Income Statement
Sources of RVTY's Revenues		Visit RVTY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RVTY's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RVTY's Growth Rates	RVTY's Roa	RVTY's Inventory Turnover Ratio	RVTY's Dividend Comparisons
RVTY's Profitability Ratios	RVTY's Roi	RVTY's Asset Turnover Ratio	RVTY's Dividend Growth
RVTY's Valuation Ratios	RVTY's Roe	RVTY's Financial Strength Ratios	RVTY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jul 05 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jul 05 2026	Receivable at quarter ending Jul 05 2026
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
The Oncology Institute Inc	9.57	$ 587.244 Millions	$ 61.364 Millions
Alumis inc	9.44	$ 7.398 Millions	$ 0.784 Millions
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
Neuronetics Inc	9.24	$ 154.594 Millions	$ 16.732 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Bioaffinity Technologies Inc	9.11	$ 5.901 Millions	$ 0.648 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biofrontera Inc	8.88	$ 45.956 Millions	$ 5.178 Millions
Grail Inc	8.85	$ 165.263 Millions	$ 18.670 Millions
Guardant Health Inc	8.84	$ 1,183.105 Millions	$ 133.772 Millions
Scientific Industries Inc	8.83	$ 5.728 Millions	$ 0.649 Millions
Sanara Medtech Inc	8.76	$ 110.116 Millions	$ 12.568 Millions
Cannapharmarx Inc	8.65	$ 1.699 Millions	$ 0.196 Millions
Fate Therapeutics Inc	8.64	$ 6.491 Millions	$ 0.751 Millions
Septerna Inc	8.64	$ 98.882 Millions	$ 11.445 Millions
10x Genomics Inc	8.63	$ 616.566 Millions	$ 71.463 Millions
Tactile Systems Technology Inc	8.58	$ 350.319 Millions	$ 40.851 Millions
Pediatrix Medical Group Inc	8.54	$ 1,950.625 Millions	$ 228.297 Millions
Volitionrx Limited	8.50	$ 2.458 Millions	$ 0.289 Millions
Ensign Group Inc	8.50	$ 5,486.708 Millions	$ 645.470 Millions

Date modified: 2026-09-05T15:29:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.